ArticleFrontiers in medicine2026

Inclisiran in advanced chronic kidney disease (stage G4-G5 non-dialysis): sustained LDL-C reduction and favorable safety profile at 1-year follow-up in a real-world case series.

Avinash Chandu Nanwani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.